Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

VTVT

vTv Therapeutics Inc.

Pharmaceutical Preparations · SIC 2834CIK 1641489Held by 1 tracked managerEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$0.0M
Net Income FY2025
$(27.0M)
EPS (Basic, as reported)
—
Net Margin FY2025
—
ROE FY2025
-41.9%
Total Equity
$64.0M
Shares Out
—
Business description

vTv Therapeutics Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2013–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 1 → 0
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue10123642010
Research & development(45)(40)(23)(15)(11)(13)(12)(14)(12)(18)
General & administrative(10)(11)(9)(9)(7)(12)(12)(12)(14)(15)
Total operating expenses(56)(51)(32)(24)(18)(26)(25)(26)(25)(33)
Operating income(55)(51)(20)(21)(12)(22)(23)(26)(24)(33)
Interest expense0(3)(3)(2)(1)00000
Interest & investment income0000000022
Other income (expense), net0—0002(4)(1)——
Pre-tax income(55)(54)(24)(22)(13)(18)(25)(26)(23)(31)
Income tax expense0(1)00000000
Net income(16)(16)(8)(13)(8)(13)(19)(20)(18)(27)

Showing the latest 10 of 13 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.